Liver Cancer Clinical Trials in Beijing, Beijing Municipality
10 recruitingBeijing, Beijing Municipality, China
Showing 1–10 of 10 trials
Recruiting
Phase 1
A Study to Assess the Safety, Tolerability, and Pharmacokinetics of ABSK-011 in Patients With Advanced Solid Tumor
Advanced Liver Cancer
Abbisko Therapeutics Co, Ltd200 enrolled32 locationsNCT04906434
Recruiting
Safety and Efficacy of Transarterial ICG Fluorescence-Guided Laparoscopic Anatomical Liver Resection
Liver Cancer
West China Hospital200 enrolled3 locationsNCT07295275
Recruiting
Not Applicable
Clinical Trial Evaluating the Safety and Efficacy of Tumor Thermosensitive Embolic Agent in Transcatheter Arterial Chemoembolization for Primary Liver Cancer
Liver Cancer
JIANGSU SHENMING Medical Technology CO., Ltd216 enrolled15 locationsNCT07356531
Recruiting
Phase 1
SON-DP in Participants With Relapsed/Refractory Intolerant to Standard of Care Therapies for Advanced/Metastatic Solid Tumors
Liver CancerGastric CancerSolid Tumor
Qurgen Inc.96 enrolled11 locationsNCT06873659
Recruiting
Effect and Mechanism of ALPPS Operation on Liver Regeneration
Liver CancerHepatobiliary CancersLiver Regeneration+1 more
Haitao Zhao, MD50 enrolled1 locationNCT07142213
Recruiting
Digital Early Warning System for Acute Lung Injury in Liver Surgery
MASLD/MASH (Metabolic Dysfunction-Associated Steatotic Liver Disease / Metabolic Dysfunction-Associated Steatohepatitis)Acute Lung Injury(ALI)Liver Cirrhosis+4 more
Beijing Tsinghua Chang Gung Hospital4,000 enrolled1 locationNCT07070362
Recruiting
TACE Combined Surgery for the Resectable Huge HCC
Liver CancerSurgeryHepatocellular Carcinoma+1 more
Sun Yat-sen University326 enrolled1 locationNCT06898398
Recruiting
HAIC Compared With TACE in Huge Hepatocellular Carcinoma
Liver CancerHepatocellular CarcinomaHepatic Chemotherapy
Sun Yat-sen University664 enrolled1 locationNCT06641713
Recruiting
Plasma Metabolic Biomarkers for Multi-Cancer Diagnosis
Breast CancerLiver CancerColorectal, Cancer+10 more
Beijing Friendship Hospital2,700 enrolled4 locationsNCT06363123
Recruiting
The Optimal Number of Fiducial Marker for Stereotactic Body Radiotherapy
Liver CancerPancreatic CancerLung Cancer+1 more
Peking University Third Hospital57 enrolled1 locationNCT06342323